Michael Henderson has been appointed as the CEO of Apogee Therapeutics.
1 report, 1 independent
Updated Aug 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Michael Henderson has been appointed as the CEO of Apogee Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Michael Henderson
vehicle safety researcher
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireApogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results Positive 16-week data from APEX Phase 2 Part A met all primary and key secondary endpoints for APG777,